Date updated:12-08-2009
This fund has a Morningstar rating of 5 stars and is run by Charles Royce. The fund is categorized as Mid-Cap blend and has an 11% turnover. The Fund invests at least 80% of its net assets in the equity securities of “premier” companies. At least 65% of these securities will be issued by companies with stock market capitalizations up to $2.5 billion at the time of investment. The fund may invest up to 25% of assets in the securities of foreign issuers. The fund looks for companies it considers “premier” that have excellent business strengths and/or prospects for growth, high internal rates of return and low leverage, and that are trading significantly below estimates of their current worth.
As of 9/30/2009 funds at Royce Premier Investments (RYPRX) were valued at $34.5 billion.
Here are the top holdings as of September 30, 2009.

-
UNT
Unit Corporation - $46.63
- 0.00%
- $N/A
2.50% of portfolio.

-
THO
Thor Industries - $32.74
- -1.44%
- $33.36
2.44% of portfolio.

-
LECO
Lincoln Electric - $52.20
- +0.64%
- $51.87
2.44% of portfolio.

-
FOSL
Fossil - $38.80
- 0.00%
- $N/A
2.27% of portfolio.

-
ESI
Itt Educational S - $109.49
- +1.21%
- $108.37
2.24% of portfolio.

-
RS
Reliance Steel & - $47.31
- +0.66%
- $47.01
2.14% of portfolio.

-
NITE
Knight Capital Gr - $16.41
- 0.00%
- $N/A
2.11% of portfolio.

-
SMS
Sims Metal Manage - $18.44
- 0.00%
- $N/A
2.09% of portfolio.
- No Blogs Found
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Calamos Advisors
- 3. Fidelity Select Pharma...
- 4. ProFunds Pharmaceutica...
- 5. BlackRock Health Scien...
- show all
- Top Do-It-Yourself Portfolios
- » jgroov Portfolio 1
- » ben johnson
- » my holdings
- » SC TRADE OF THE DAY
- » kudos
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on March 10, 2010, at 10:44 a.m. If there’s one industry that traders like to target, it’s the pharmaceutical indsutry. After all, pharma ...
By Jonas Elmerraji Posted on March 9, 2010 Stock futures look set to take a pause on Tuesday, following a sizable rally that pushed the S&P 500 from just above 1100 all...
Posted on March 9, 2010 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is to gather as much i...
By Roberto Pedone Posted on March 8, 2010 Top Natural-Resource Plays: Barron’s talks with MacKenzie Davis and Ken Settles, co-managers of the RS Global Natural Resour...
A. I'm looking to cut 10% by friday also.
A. The only one I own : SLX,
too hard pick a winner out all of them
Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more
Here are some of the largest % gainers from Mar. 10, 2010. more
Below is a list of some of the companies that have their ex-dividend date Wednesday, Mar. 10, 2010. What is the ex-dividend date? According to Dividends.com: The ex-... more













03/12/2007 20:44 PM CDT Asked by Goldy
good ideas but I would put mume.pk in your picks because they have a movie coming out which could have it going to $1
01/27/2007 01:01 AM CST Asked by magician
It's hard to understand why Morningstar would give this portfolio a 4-star rating. Over the last five years LECO, THO, FRK, WGO, MDG, BIG and RS have added no useful diversification. Furthermore, this portfolio is nowhere near efficient: it has about twice the risk that it should for the return its earning.